Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Dow
Federal Trade Commission
Julphar
UBS
US Army
McKinsey
QuintilesIMS
US Department of Justice
Express Scripts

Generated: February 24, 2018

DrugPatentWatch Database Preview

Latanoprost - Generic Drug Details

« Back to Dashboard

What are the generic sources for latanoprost and what is the scope of latanoprost patent protection?

Latanoprost
is the generic ingredient in three branded drugs marketed by Akorn, Amring Pharms, Apotex Inc, Bausch And Lomb, Dr Reddys Labs Ltd, Fdc Ltd, Mylan, Sandoz Inc, and Pharmacia And Upjohn, and is included in ten NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for latanoprost. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for latanoprost
Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Tentative approvals for LATANOPROST
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial0.005%SOLUTION; OPHTHALMIC

US Patents and Regulatory Information for latanoprost

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Fdc Ltd LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 202442-001 Apr 22, 2016 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Amring Pharms LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 200925-001 Mar 22, 2011 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 091449-001 Mar 22, 2011 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 201786-001 Mar 22, 2011 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 202077-001 Feb 11, 2013 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Bausch And Lomb LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 201006-001 Mar 22, 2011 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for latanoprost

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Covington
US Department of Justice
Chinese Patent Office
UBS
McKinsey
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot